Their research clearly separates the functions of TIE-1 from TIE-2, revealing that TIE-1 overexpression correlates with poor prognosis and lower effectiveness of cisplatin in advanced ovarian cancer. This evidence concerns the gene TIE1 and ovarian cancer.